United Kingdom Hemp Derived CBD Oil Market Size & Outlook, 2026-2034

United Kingdom Hemp Derived CBD Oil Market Insights

Based on Deep Market Insights findings, the United Kingdom Hemp Derived CBD Oil Market reached USD 10.36 Million in 2025 and is estimated to attain USD 33.69 Million by 2034.
From 2026 to 2034, the United Kingdom market is expected to grow at a steady CAGR of 13.95%.
Within the By Type category, Full-spectrum CBD oil dominated in 2025 in terms of market size contribution.
Over the forecast period, CBD isolate oil is forecasted to deliver the fastest growth, positioning it as the most lucrative By Type segment.

In 2025, United Kingdom accounted for 4.32% of the global Hemp Derived CBD Oil Market size.
By 2034, United States is expected to lead the global Hemp Derived CBD Oil Market in terms of market size.
Within Europe, Germany is projected to dominate the regional Hemp Derived CBD Oil Market size by 2034.
Russia is identified as the fastest-growing market in Europe, anticipated to reach USD 13.23 Million by 2034.

Report Scope	Details
Base Year for Study	2025
Study Period	2022-2034
Historical Period	2022-2024
Forecast Period	2026-2034
Market Size In 2025	USD 10.36 Million
Market Size In 2034	USD 33.69 Million
Largest segment	Full-spectrum CBD oil
Units	Revenue in USD Million
CAGR	13.95% (2026-2034)
Segmnetation Covered
By Type	Full-spectrum CBD oil Broad-spectrum CBD oil CBD isolate oil Organic CBD oil
By Form	Tinctures Capsules Topicals Edibles
By Application	Pain relief Anxiety & stress Wellness Sleep support
By Distribution Channel	Pharmacies Online retail Dispensaries Health stores
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

By Type	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Full-spectrum CBD oil	XX.x	XX.x	XX.x	5.01	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Broad-spectrum CBD oil	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
CBD isolate oil	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Organic CBD oil	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

By Form	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Tinctures	XX.x	XX.x	XX.x	4.99	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Capsules	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Topicals	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Edibles	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

By Application	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Pain relief	XX.x	XX.x	XX.x	4.19	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Anxiety & stress	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Wellness	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Sleep support	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

By Distribution Channel	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Pharmacies	XX.x	XX.x	XX.x	4.26	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Online retail	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Dispensaries	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Health stores	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x